# Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

> **NCT01818661** · PHASE4 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 50 (estimated)

## Conditions studied

- PPA
- Non-fluent Aphasia
- Apraxia of Speech
- Primary Progressive Non-fluent Aphasia
- Primary Progressive Aphasia

## Interventions

- **DRUG:** AV-1451

## Key facts

- **NCT ID:** NCT01818661
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-01
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01818661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01818661, "Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01818661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*